IGC IGC Pharma, Inc.: institutional ownership and insider trading
40 funds reported holding $1.75M of IGC Pharma, Inc. in their latest 13F filings; in Q2 2026 funds net bought $239K, with 6 new positions and 4 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding IGC
- Ken Griffin (Citadel Advisors): $119K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $78.0K, 0.0% of the portfolio
Largest institutional holders of IGC
- VANGUARD GROUP INC — $323K
- GEODE CAPITAL MANAGEMENT, LLC — $239K
- VANGUARD CAPITAL MANAGEMENT LLC — $222K
- BlackRock, Inc. (BLK) — $191K
- AdvisorShares Investments LLC — $185K
- CITADEL ADVISORS LLC — $119K
- VANGUARD FIDUCIARY TRUST CO — $114K
- RENAISSANCE TECHNOLOGIES LLC — $78.0K
- STATE STREET CORP (STT, STT-PG) — $54.6K
- NORTHERN TRUST CORP (NTRS, NTRSO) — $46.3K